{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:32:31Z","timestamp":1790814751759,"version":"4.1.0"},"reference-count":24,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precision Oncology"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>PURPOSE<\/jats:title><jats:p> High-risk clonal hematopoiesis (CH) is frequently incidentally found in patients with solid tumors undergoing plasma cell\u2013free DNA sequencing. Here, we aimed to determine if the incidental detection of high-risk CH by liquid biopsy may reveal occult hematologic malignancies in patients with solid tumors. <\/jats:p><\/jats:sec><jats:sec><jats:title>MATERIALS AND METHODS<\/jats:title><jats:p> Adult patients with advanced solid cancers enrolled in the Gustave Roussy Cancer Profiling study (ClinicalTrials.gov identifier: NCT04932525 ) underwent at least one liquid biopsy (FoundationOne Liquid CDx). Molecular reports were discussed within the Gustave Roussy Molecular Tumor Board (MTB). Potential CH alterations were observed, and patients referred to hematology consultation in the case of pathogenic mutations in JAK2, MPL, or MYD88, irrespective of the variant allele frequency (VAF), or in DNMT3A, TET2, ASXL1, IDH1, IDH2, SF3B1, or U2AF1 with VAF \u2265 10%, while also considering patient cancer-related prognosis. TP53 mutations were discussed case-by-case. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p> Between March and October 2021, 1,416 patients were included. One hundred ten patients (7.7%) carried at least one high-risk CH mutation: DNMT3A (n = 32), JAK2 (n = 28), TET2 (n = 19), ASXL1 (n = 18), SF3B1 (n = 5), IDH1 (n = 4), IDH2 (n = 3), MPL (n = 3), and U2AF1 (n = 2). The MTB advised for hematologic consultation in 45 patients. Overall, 9 patients of 18 actually addressed had confirmed hematologic malignancies that were occult in six patients: two patients had myelodysplastic syndrome, two essential thrombocythemia, one a marginal lymphoma, and one a Waldenstr\u00f6m macroglobulinemia. The other three patients were already followed up in hematology. <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p> The incidental findings of high-risk CH through liquid biopsy may trigger diagnostic hematologic tests and reveal an occult hematologic malignancy. Patients should have a multidisciplinary case-by-case evaluation. <\/jats:p><\/jats:sec>","DOI":"10.1200\/po.22.00583","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T20:59:14Z","timestamp":1677790754000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":19,"title":["Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-051X","authenticated-orcid":false,"given":"Mihaela","family":"Aldea","sequence":"first","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"University of Paris Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7461-023X","authenticated-orcid":false,"given":"Marco","family":"Tagliamento","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-7906","authenticated-orcid":false,"given":"Arnaud","family":"Bayle","sequence":"additional","affiliation":[{"name":"University of Paris Saclay, Paris, France"},{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-1498","authenticated-orcid":false,"given":"Damien","family":"Vasseur","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3233-5978","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Verg\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-1984","authenticated-orcid":false,"given":"Arianna","family":"Marinello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Danlos","sequence":"additional","affiliation":[{"name":"University of Paris Saclay, Paris, France"},{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-1515","authenticated-orcid":false,"given":"Felix","family":"Blanc-Durand","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-7187","authenticated-orcid":false,"given":"Elsa","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cerbone","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"Mosele","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-9640","authenticated-orcid":false,"given":"Aline","family":"Renneville","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-3289","authenticated-orcid":false,"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1739","authenticated-orcid":false,"given":"Yohann","family":"Loriot","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madona","family":"Sakkal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Vozy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementine","family":"Sarkozy","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Smolenschi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Nicotra","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-5160","authenticated-orcid":false,"given":"Patricia","family":"Martin-Romano","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-1491","authenticated-orcid":false,"given":"Clementine","family":"Boccon-Gibod","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafikaamira","family":"Habza","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lazarovici","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ponce","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-7551","authenticated-orcid":false,"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-0376","authenticated-orcid":false,"given":"Christophe","family":"Marzac","sequence":"additional","affiliation":[{"name":"Drug Development Department, Gustave Roussy, Villejuif, France"},{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-1010","authenticated-orcid":false,"given":"Ludovic","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-8357","authenticated-orcid":false,"given":"Fabrice","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"University of Paris Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-8189","authenticated-orcid":false,"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"University of Paris Saclay, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-5668","authenticated-orcid":false,"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-5351","authenticated-orcid":false,"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gustave Roussy, Villejuif, France"},{"name":"Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0934-294X","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Micol","sequence":"additional","affiliation":[{"name":"University of Paris Saclay, Paris, France"},{"name":"Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.07.010"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00710-0"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.6053"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0901"},{"key":"b7","first-page":"1599","volume":"136","author":"Warren JT","year":"2020","journal-title":"Blood"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0081-z"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769869"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01521-4"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.62"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1111708"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.088740"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-391748"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0652-7"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237802"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.172718"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.002"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000632"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5161"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO.22.00583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T20:59:18Z","timestamp":1677790758000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO.22.00583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1200\/PO.22.00583"],"URL":"https:\/\/doi.org\/10.1200\/po.22.00583","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"2022-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2200583"}}